The cardiac action potential phases represent the sequential electrical events that govern myocardial contraction and relaxation. Each phase reflects the coordinated opening and closing of ion channels, creating a precisely timed electrical signal that propagates through the heart muscle. And understanding these phases is essential for cardiology students, clinicians, and researchers, as they underlie normal heart rhythm and serve as the foundation for diagnosing and treating arrhythmias. This article provides an in-depth exploration of the five recognized phases of the cardiac action potential, their ionic mechanisms, cellular variations, and clinical relevance.
The Five Phases of a Typical Ventricular Myocyte Action Potential
In most textbook descriptions, a cardiac action potential recorded from a ventricular myocyte is divided into five distinct phases: Phase 0 through Phase 4. Each phase is characterized by specific changes in membrane potential and the dominant ionic currents responsible for those changes.
Phase 0: Rapid Depolarization Phase 0 marks the upstroke of the action potential. In ventricular and atrial myocytes, this is driven by the rapid influx of sodium ions (Na⁺) through fast sodium channels (Nav1.5). These channels open almost instantaneously upon depolarization to threshold, allowing a massive inward current that quickly raises the membrane potential from approximately -
raising the membrane potential from approximately –90 mV to about +30 mV within 1–2 ms. In real terms, 5 channels (I_Na) is responsible for this swift upstroke. The rapid influx of Na⁺ through Nav1.Which means these channels have a high open probability at membrane potentials near –70 mV and inactivate within a few milliseconds, thereby limiting the duration of the depolarizing current. The magnitude and speed of Phase 0 are crucial for the propagation velocity of the electrical impulse through the ventricular wall; any reduction in I_Na (as seen with sodium‑channel blockers or certain genetic mutations) broadens the QRS complex and can predispose to conduction slowing or block Worth keeping that in mind..
Counterintuitive, but true Easy to understand, harder to ignore..
Phase 1: Early Repolarization
Immediately after the peak of the action potential, a brief, transient outward current initiates the first stage of repolarization. The dominant current during Phase 1 is the transient outward potassium current (I_to), mediated by Kv4.2/4.3 channels in human ventricles. I_to is rapidly activated by the depolarization of Phase 0 and then quickly inactivated, producing a characteristic “notch” on the action‑potential tracing. In some species, a chloride current (I_Cl,Ca) and the inactivation of Na⁺ channels also contribute to this early repolarization. The notch separates the rapid depolarization from the subsequent plateau, and its depth influences the susceptibility to certain forms of ventricular arrhythmia, notably those associated with Brugada syndrome That alone is useful..
Phase 2: Plateau
The plateau phase maintains the membrane potential near +10 mV for roughly 200–300
Phase 2: The Plateau
The plateau maintains the membrane potential in the range of +10 to +20 mV for 200–350 ms, a period that distinguishes cardiac cells from most neuronal action potentials. The delicate balance of inward and outward currents during this interval determines the length of the refractory period and, consequently, the heart’s vulnerability to re‑entrant circuits.
The L‑type calcium current (I_CaL) is the principal depolarizing force. It activates relatively slowly (τ ≈ 10–30 ms) and reaches a peak around +10 mV, delivering a sustained Ca²⁺ influx that not only contributes to the plateau voltage but also triggers calcium‑induced calcium release from the sarcoplasmic reticulum, linking electrical activity to contraction.
Conversely, several outward currents oppose this influx. The rapid delayed rectifier potassium current (I_Kr) and the sustained delayed rectifier current (I_Ks) open in response to depolarization and gradually increase potassium efflux, pulling the membrane potential back toward the resting state. The Na⁺/Ca²⁺ exchanger (I_NaCa) also operates in reverse mode during the plateau, extruding one Ca²⁺ in exchange for three Na⁺ influxes, modestly augmenting depolarization.
Regulatory mechanisms such as protein kinase A (PKA)–mediated phosphorylation and calcium‑dependent inactivation fine‑tune I_CaL magnitude, while IKs upregulation provides a protective increase in repolarizing capacity during β‑adrenergic stimulation. Disruptions in this equilibrium—e.Practically speaking, g. , reduced I_CaL activity or exaggerated I_Kr block—prolong the plateau and can precipitate torsades de pointes.
Phase 3: Rapid Repolarization
When the inward currents wane and outward potassium currents dominate, the membrane rapidly repolarizes to near‑resting levels. Now, the closure of I_CaL (through calcium‑dependent inactivation and voltage‑dependent inactivation) removes the primary depolarizing drive. Simultaneously, I_Kr and I_Ks reach maximal conductance, and the ultra‑rapid delayed rectifier current (I_Kur), though minor in ventricular myocytes, contributes to the final repolarization slope Worth keeping that in mind..
The Na⁺/K⁺‑ATPase gradually restores ionic gradients, while the Na⁺/Ca²⁺ exchanger shifts back to forward mode, extruding Ca²⁺ and importing Na⁺. The net result is a steep decline in membrane potential that brings the cell back to the resting state within 100–150 ms, completing the action‑potential cycle Surprisingly effective..
Phase 4: Resting Membrane Potential
Phase 4 represents the inter‑beat interval, during which the ventricular myocyte maintains a stable hyperpolarized membrane potential of approximately –85 mV. This resting potential is primarily set by the electrochemical gradient for potassium and the high resting permeability of the membrane to K⁺ through inward‑rectifier channels (I_K1) Most people skip this — try not to..
I_K1 conducts K⁺ efflux when the membrane potential is more positive than the K⁺ equilibrium potential, stabilizing the cell at a negative voltage and preventing depolarization. And the Na⁺/K⁺‑ATPase actively maintains the intracellular Na⁺ and K⁺ concentrations, while the Na⁺/Ca²⁺ exchanger helps keep cytosolic Ca²⁺ low. Together, these ionic mechanisms create a solid baseline that ensures the cell is ready to respond to the next depolarizing stimulus.
Easier said than done, but still worth knowing.
Cellular Variations
While the canonical five‑phase pattern is a useful teaching framework, real cardiac tissue exhibits notable heterogeneity.
- Atrial myocytes display a shorter plateau (≈150 ms) and a less pronounced Phase 1 notch, reflecting their faster conduction and different expression ratios of I_to and I_Kp.
- Purkinje fibers possess an abbreviated Phase 2, allowing ultra‑rapid propagation through the conduction system; they rely heavily on I_Na and I_K1, with reduced I_CaL contribution.
- Sinoatrial node (SA) cells lack a true plateau; their action potential is dominated by a pacemaker current (If) and a modest Ca²⁺ influx, resulting in spontaneous depolarization from Phase 4 to Phase 0 without a distinct plateau phase.
These variations underlie the specialized electrophysiological roles of each cell type and explain why certain channelopathies manifest preferentially
in specific cardiac regions. Take this: mutations affecting I_Kr (encoded by KCNH2) often lead to Long QT Syndrome type 2, manifesting as arrhythmias triggered by sudden auditory stimuli, while defects in the sodium channel I_Na (encoded by SCN5A) are linked to Long QT Syndrome type 3 and Brugada Syndrome, which predominantly affect the right ventricle and can cause syncope or sudden cardiac death in young individuals.
Clinical Correlations
Understanding the ionic basis of the cardiac action potential has profound therapeutic implications. Worth adding: class I antiarrhythmic drugs primarily target I_Na, reducing the rate of depolarization and slowing conduction velocity. Class III agents, such as amiodarone or sotalol, prolong the action potential duration by blocking various K⁺ channels, thereby extending repolarization. Meanwhile, beta-adrenergic agonists enhance I_CaL and accelerate heart rate, whereas calcium channel blockers diminish I_CaL, reducing myocardial contractility and conduction through the AV node Simple, but easy to overlook..
Beyond that, the concept of early afterdepolarizations (EADs) and delayed afterdepolarizations (DADs) arises directly from disturbances in these currents. EADs, occurring during Phases 2 or 3, are associated with prolonged repolarization syndromes, whereas DADs, emerging post-repolarization, stem from intracellular calcium overload—often seen in catecholaminergic polymorphic ventricular tachycardia (CPVT).
Computational Modeling
The integration of experimental data into mathematical models, such as the Luo-Rudy model, has enabled researchers to simulate action potentials under normal and pathological conditions. This leads to these models incorporate dynamic representations of ion channel kinetics, calcium handling, and cellular coupling, offering insights into drug effects, disease mechanisms, and personalized treatment strategies. As precision medicine advances, computational cardiology is poised to bridge the gap between genotype and phenotype, refining risk stratification and therapy selection.
Conclusion
The cardiac action potential is a finely tuned interplay of ion channels, pumps, and exchangers, orchestrated across five distinct phases that ensure coordinated contraction and relaxation. Now, from the rapid influx of sodium initiating depolarization to the sustained calcium entry sustaining contraction, each phase reflects a unique constellation of molecular actors. Variations among cell types highlight the functional specialization within the heart, while disruptions in this delicate balance underlie numerous arrhythmias and inherited disorders Less friction, more output..
Continued exploration of cardiac electrophysiology—not only at the bedside and bench but also through advanced modeling techniques—promises to unveil novel therapeutic targets and refine our ability to predict, prevent, and treat cardiovascular diseases. As we peer deeper into the microscopic world of ion channels and cellular dynamics, the macroscopic symphony of the heartbeat becomes ever more comprehensible, bringing us closer to mastering its rhythm.
